Evidence map›Paper›PMID 42866438›Full record

ArticleACS medicinal chemistry letters2026

Fragment OptimizationSimple SMILES String Manipulation Strategies to Optimize a Hit or Fragment.

Kevin P Cusack, Jake M Aquilina

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kevin P CusackAbbVie Bioresearch Center, 381 Plantation St., Worcester, Massachusetts 01605, United States.ORCID https://orcid.org/0000-0002-1858-0213
Jake M AquilinaAbbVie Bioresearch Center, 381 Plantation St., Worcester, Massachusetts 01605, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AI/ML-based tools for generative and predictive modeling have become important contributors to small molecule drug discovery, enabling virtual compound design and ADME profiling prior to synthesis. Alongside these methods, simpler nonlearned strategies based on direct SMILES manipulation remain useful, particularly for low data targets. Herein is described a method for fragment optimization in which characters of a SMILES string are systematically replaced with alternative SMILES patterns to generate atom-type swaps, ring expansion/contraction, cyclization, ring opening, and fragment grafts. The method was initially implemented as a KNIME workflow and demonstrated on fragment-to-lead optimization of fragments from several programs. A fully open-source counterpart written in Python utilizing AutoDock Vina is also provided. Together, these tools are used in parallel with alternative open-source and commercial solutions to accelerate fragment-to-lead optimization through iterative

Indexed as

AIartificial intelligencede novo designgenerative modelinggenetic algorithmmachine learningML

Identifiers

PMID42866438
PMCPMC13656279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.